Major Market Shift in Gastrointestinal Pathogen Testing Industry: Advancements In Gastrointestinal Pathogen Testing

What Is the Forecasted Market Size and Growth Rate for the Gastrointestinal Pathogen Testing Market?
The market size for gastrointestinal pathogen testing has seen a consistent growth lately. Projected to surge from $4.05 billion in 2024 to $4.24 billion in 2025, it is expected to grow at a compound annual growth rate (CAGR) of 4.6%. The growth observed during the historic period can be ascribed to factors such as the amplified cases of gastrointestinal infections, increased understanding of foodborne diseases, heightened interconnectivity leading to a surge in travel-related infections, regulatory measures promoting food safety, enhanced healthcare spending, as well as an escalated demand for rapid and precise diagnostic tools.

Anticipations for continued expansion are being projected for the gastrointestinal pathogen testing market in the coming years. By 2029, it is predicted to reach $5.01 billion with a compound annual growth rate (CAGR) of 4.3%. This anticipated growth during the forecast period is linked to a rise in the global instances of gastrointestinal infections, increased understanding of the significance of early diagnosis and intervention, improved healthcare structures in developing economies, increased need for point-of-care testing solutions, intensified emphasis on food safety rules, and ongoing research and development contributions. The forecast period is set to see trends like quick testing approaches, increased use of molecular diagnostic methods, the broadening of point-of-care testing in non-traditional healthcare environments, progress in automation and robotics aimed at optimizing testing procedures, the discovery of new biomarkers for improved pathogen detection, and the incorporation of artificial intelligence and machine learning.

What Is Driving the Growth Trajectory of the Gastrointestinal Pathogen Testing Market?
The increase in occurrences of diseases transmitted through food is anticipated to accelerate the expansion of the gastrointestinal pathogen testing market. Foodborne illnesses arise from the consumption of food or drinks tainted with pathogens, toxins, or chemical substances. Conditions such as listeriosis, viral gastroenteritis, taeniasis, and trichinosis fall under this category. The hike in these incidents can be attributed to various elements, such as adjustments in food production, distribution, and eating habits, insubstantial food security protocols, and the effects of climate change on food manufacturing. Gastrointestinal examinations are beneficial in detecting the precise pathogens causing these illnesses, enabling medical experts to ascertain the origin of gastrointestinal symptoms, prescribe relevant treatment, trace outbreaks, and set up protective steps to lessen the propagation of these diseases. For example, in February 2024, the UK Health Security Agency cited 167 instances of listeriosis in England and Wales in 2022, which is higher than the 160 cases recorded in 2021. Consequently, the mounting occurrences of foodborne diseases are spurring the expansion of the gastrointestinal pathogen testing market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15571&type=smp

Which Businesses Are at the Forefront of Gastrointestinal Pathogen Testing Market Development?
Major companies operating in the gastrointestinal pathogen testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Becton Dickinson and Company, Hologic Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Cepheid Inc., OraSure Technologies Inc., BioFire Diagnostics Inc., Luminex Corporation, Meridian Bioscience Inc., Sekisui Diagnostics LLC, ELITechGroup S.A.S., Hardy Diagnostics LLC, Trinity Biotech plc, Puritan Medical Products Co. LLC, Cosmo Bio Co. Ltd., R-Biopharm AG, COPAN Diagnostics Inc., Savyon Diagnostics Ltd., ZeptoMetrix Corporation, Biomerica Inc., Pro-Lab Diagnostics

What Are the Latest Innovations in the Gastrointestinal Pathogen Testing Market?
Leading enterprises in the gastrointestinal pathogen testing market have prioritized the development of innovative solutions, such as metagenomic diagnostic examinations, to improve efficiency, precision, and overall detection capabilities for gastrointestinal pathogens. This sophisticated technology is utilized to examine the genetic components of microorganisms contained in samples such as blood or stool. In a case-for-case example, Microba Life Sciences, a biotech firm based in Australia, launched MetaPanel, a type of metagenomic diagnostic examination capable of identifying an extensive array of gastrointestinal pathogens with unmatched precision in April 2024. MetaPanel is capable of targeting 175 pathogens through one test, providing medical practitioners with a comprehensive tool for diagnosing both commonly occurring and difficult to identify infections. Using the power of Next-Generation Sequencing (NGS) technology, it analyses a wide range of genetic material in fecal matter, enabling detection of a vast spectrum of potential pathogens, even those normally not included in conventional GI (gastrointestinal) panels.

How Is the Gastrointestinal Pathogen Testing Market Segmented?
The gastrointestinal pathogen testing market covered in this report is segmented -

1) By Pathogen Type: Bacteria, Viruses, Parasites
2) By Test Type: Molecular Tests, Culture, Biochemical Tests, Other Test Types
3) By Panel Type: Syndromic Full Multiplex Panels, Other Panel Types
4) By End-User: Hospitals, Diagnostic Laboratories, Point-Of-Care, Other End Users

Subsegments:
1) By Bacteria: Salmonella spp., Escherichia coli, Campylobacter spp., Shigella spp., Clostridium difficile, Vibrio spp., Listeria monocytogenes, Helicobacter pylori, Other Bacterial Pathogens
2) By Viruses: Norovirus, Rotavirus, Enteric Adenovirus, Hepatitis A Virus (HAV), Astrovirus, Other Viral Pathogens
3) By Parasites: Giardia lamblia, Entamoeba histolytica, Cryptosporidium spp., Trichinella spp., Toxoplasma gondii, Other Parasitic Pathogens

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/gastrointestinal-pathogen-testing-global-market-report

Where Is the Gastrointestinal Pathogen Testing Market Growth Most Prominent?
North America was the largest region in the gastrointestinal pathogen testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal pathogen testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Gastrointestinal Pathogen Testing Global Market Report?

- Market Size Analysis: Analyze the Gastrointestinal Pathogen Testing Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Gastrointestinal Pathogen Testing Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Gastrointestinal Pathogen Testing Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Gastrointestinal Pathogen Testing Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15571

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.